These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10427143)

  • 1. Determination of telomerase activity in multifocal renal cell carcinoma.
    Schlichter A; Fiedler W; Junker K; Dahse R; Claussen U; Schubert J
    Int J Oncol; 1999 Sep; 15(3):577-81. PubMed ID: 10427143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of telomerase activity for differential analysis of multifocal renal cell carcinomas.
    Fiedler W; Junker K; Schlichter A; Schubert J; Ernst G; Dahse R; Claussen U
    Kidney Int; 1999 Oct; 56(4):1286-8. PubMed ID: 10504476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where are the limits of elective nephron- sparing surgery in renal cell carcinoma?
    Schlichter A; Wunderlich H; Junker K; Kosmehl H; Zermann DH; Schubert J
    Eur Urol; 2000 May; 37(5):517-20. PubMed ID: 10765088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in human renal cell carcinoma.
    Fujioka T; Hasegawa M; Suzuki Y; Suzuki T; Sugimura J; Tanji S; Koike H
    Int J Urol; 2000 Jan; 7(1):16-21. PubMed ID: 10701886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in renal cell carcinoma.
    Yoshida K; Sakamoto S; Sumi S; Higashi Y; Kitahara S
    Cancer; 1998 Aug; 83(4):760-6. PubMed ID: 9708942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity in malignant and benign renal tumors.
    Müller M; Heicappell R; Krause H; Sachsinger J; Porsche C; Miller K
    Eur Urol; 1999; 35(3):249-55. PubMed ID: 10072629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity in human renal cell carcinoma.
    Sugimura K; Yoshida N; Hisatomi H; Nakatani T; Ikemoto S
    BJU Int; 1999 Apr; 83(6):693-7. PubMed ID: 10233581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic changes and telomerase activity in human renal cell carcinoma.
    Rohde V; Sattler HP; Oehlenschläger B; Forster S; Zwergel T; Seitz G; Wullich B
    Clin Cancer Res; 1998 Jan; 4(1):197-202. PubMed ID: 9516971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity in renal cell carcinoma by modified telomeric repeat amplification protocol assay.
    Segawa N; Gohji K; Azuma H; Iwamoto Y; Ohnishi K; Katsuoka Y
    Int J Urol; 2003 Mar; 10(3):153-9. PubMed ID: 12622712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma.
    Kinoshita H; Ogawa O; Mitsumori K; Kakehi Y; Terachi T; Yoshida O
    J Urol; 1998 Jan; 159(1):245-51. PubMed ID: 9400489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
    Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
    Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
    Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
    World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal surgical margin in nephron-sparing surgery for T1b renal cell carcinoma.
    Chen XS; Zhang ZT; Du J; Bi XC; Sun G; Yao X
    Urology; 2012 Apr; 79(4):836-9. PubMed ID: 22305422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of multifocal renal cell carcinoma by comparative genomic hybridization.
    Junker K; Hindermann W; Schubert J; Schlichter A
    Anticancer Res; 1999; 19(2C):1487-92. PubMed ID: 10365129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
    Hafez KS; Novick AC; Butler BP
    J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue.
    Rohde V; Sattler HP; Bund T; Bonkhoff H; Fixemer T; Bachmann C; Lensch R; Unteregger G; Stoeckle M; Wullich B
    Clin Cancer Res; 2000 Dec; 6(12):4803-9. PubMed ID: 11156238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
    Simhan J; Canter DJ; Sterious SN; Smaldone MC; Tsai KJ; Li T; Viterbo R; Chen DY; Greenberg RE; Kutikov A; Uzzo RG
    J Urol; 2013 Jan; 189(1):43-7. PubMed ID: 23164383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and telomere lengths: alterations in renal cell carcinomas.
    Dahse R; Fiedler W; Junker K; Schlichter A; Schubert J; Claussen U
    Kidney Int; 1999 Oct; 56(4):1289-90. PubMed ID: 10504477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma.
    Mehle C; Lindblom A; Ljungberg B; Stenling R; Roos G
    Int J Oncol; 1998 Aug; 13(2):289-95. PubMed ID: 9664124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.